￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Alectinib creates a miracle of 62.5% long-term survival in ALK-positive NSCLC

2025-10-19 11:44:20

Check Details
The new lung cancer targeting drug aletinib can extend the survival time of lung cancer patients by 3 times!

2025-10-19 11:44:20

Check Details
The first generation of ALK-targeted drug-crizotinib

2025-10-19 11:44:20

Check Details
Do you really know about the lung cancer targeted drug crizotinib?

2025-10-19 11:44:20

Check Details
An in-depth analysis of the miracle drug for lung cancer - osimertinib

2025-10-19 11:44:20

Check Details
Life-saving straw for lung cancer patients: Osimertinib

2025-10-19 11:44:20

Check Details
Afatinib prolongs overall survival in Asian patients with non-small cell lung cancer _ Kanghule

2025-10-19 11:44:20

Check Details
How much does afatinib cost? Can I buy it in Weifang?

2025-10-19 11:44:20

Check Details
FDA approves erlotinib for first-line treatment of metastatic NSCLC_ Kanghule

2025-10-19 11:44:20

Check Details
Targeted drug for lung cancer - Tarceva (erlotinib)

2025-10-19 11:44:20

Check Details
Which generation of targeted drug is gefitinib? Does it work well?

2025-10-19 11:44:20

Check Details
Gefitinib, a first-line treatment drug for non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Category
相关知识